DRONTAL (230+20)MG/TAB ΕΠΙΚΑΛΥΜΜΕΝΟ ΔΙΣΚΙΟ
DRONTAL (230+20)MG/TAB ΕΠΙΚΑΛΥΜΜΕΝΟ ΔΙΣΚΙΟ
Authorised
- Praziquantel
- Pyrantel embonate
Product identification
Medicine name:
DRONTAL (230+20)MG/TAB ΕΠΙΚΑΛΥΜΜΕΝΟ ΔΙΣΚΙΟ
Active substance:
- Praziquantel
- Pyrantel embonate
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Praziquantel20.00/milligram(s)1.00Tablet
-
Pyrantel embonate230.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Coated tablet
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AA51
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Available in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- KVP Pharma+Veterinaer Produkte GmbH
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 35797/07-05-2013/K-0106101
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet